Exploring the role of renal pharmacists in outpatient dialysis centres: A qualitative study

International Journal of Clinical Pharmacy

Volumn 34, Issue 4, 2012, Pages 569-578

  Salgado, Teresa M ^a   Moles, Rebekah ^b   Benrimoj, Shalom I ^c   Fernandez Llimos, Fernando ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Australia; Haemodialysis centres; Outpatients; Pharmacists; Qualitative research; Theory of planned behaviour

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; ATTITUDE; AUSTRALIA; CLINICAL PRACTICE; CLINICAL PROTOCOL; COGNITION; HEMODIALYSIS PATIENT; HOSPITAL DEPARTMENT; HUMAN; MEDICAL SPECIALIST; NEPHROLOGIST; NURSE; OUTPATIENT CARE; PATIENT EDUCATION; PERSONNEL SHORTAGE; PHARMACIST; PHARMACIST ATTITUDE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; RENAL PHARMACIST; SEMI STRUCTURED INTERVIEW;

ADULT; ATTITUDE OF HEALTH PERSONNEL; COMMUNITY PHARMACY SERVICES; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PHARMACISTS; PROFESSIONAL ROLE; QUALITATIVE RESEARCH; RENAL DIALYSIS;

EID: 84867397583     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-012-9645-z     Document Type: Article

References (42)

1. Chisholm-Burns MA, Kim Lee J, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, et al. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48(10):923-33.
2. Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008;168(7): 687-94.
3. Boudreau DM, Capoccia KL, Sullivan SD, Blough DK, Ellsworth AJ, Clark DL, et al. Collaborative care model to improve outcomes in major depression. Ann Pharmacother. 2002;36(4): 585-91.
4. Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review. Nephrol Dial Transplant. 2012;27(1):276-92.
5. Stemer G, Lemmens-Gruber R. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC Nephrol. 2011;12(1):35.
6. Pai AB, Boyd A, Depczynski J, Chavez IM, Khan N, Manley H. Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study. Pharmacotherapy. 2009;29(12):1433-40.
7. Leung WY, So WY, Tong PC, Chan NN, Chan JC. Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy. Am J Med. 2005; 118(12):1414.
8. Yokum D, Glass G, Cheung CF, Cunningham J, Fan S, Madden AM. Evaluation of a phosphate management protocol to achieve optimum serum phosphate levels in hemodialysis patients. J Ren Nutr. 2008;18(6):521-9.
9. Bucaloiu ID, Akers G, Bermudez MC, Mainali R, Brown BL, Roberts SS, et al. Outpatient erythropoietin administered through a protocol-driven, pharmacist-managed program may produce significant patient and economic benefits. Manag Care Interface. 2007;20(6):26-30.
10. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Implementing cognitive services in community pharmacy: a review of models and frameworks for change. Int J Pharm Pract. 2006;14(2):105-13.
11. Gastelurrutia MA, Fernandez-Llimos F, Benrimoj SI, Castrillon CC, Faus MJ. Barriers for the implementation of cognitive services in Spanish community pharmacies. Aten Primaria. 2007;39(9):465-70.
12. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Implementing cognitive services in community pharmacy: a review of facilitators used in practice change. Int J Pharm Pract. 2006;14(3):163-70.
13. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother. 2008;42(6):861-8.
14. Rossing C, Hansen EH, Krass I. Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacies. J Soc Admin Pharm. 2001;19(2):55-64.
15. Saini B, Krass I, Armour C. Specialisation in asthma: current practice and future roles. J Soc Admin Pharm. 2000;18(5): 169-77.
16. Farris KB, Schopflocher DP. Between intention and behavior: an application of community pharmacists' assessment of pharmaceutical care. Soc Sci Med. 1999;49(1):55-66.
17. Feletto E, Wilson LK, Roberts AS, Benrimoj SI. Flexibility in community pharmacy: a qualitative study of business models and cognitive services. Pharm World Sci. 2010;32(2):130-8.
18. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Hopp TR, Aslani P. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Social Adm Pharm. 2005;1(4):546-64.
19. Benrimoj SI, Feletto E, Gastelurrutia MA, Martinez Martinez F, Faus MJ. A holistic and integrated approach to implementing cognitive pharmaceutical services. Ars Pharm. 2010;51(2):69-87.
20. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50:179-211.
21. Herbert KE, Urmie JM, Newland BA, Farris KB. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Res Social Adm Pharm. 2006;2(3):299-314.
22. Perkins MB, Jensen PS, Jaccard J, Gollwitzer P, Oettingen G, Pappadopulos E, et al. Applying theory-driven approaches to understanding and modifying clinicians' behavior: what do we know? Psychiatr Serv. 2007;58(3):342-8.
23. Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, Steinhardt M. Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior. Res Social Adm Pharm. 2010;7(4):369-82.
24. Rashidian A, Russell I. Intentions and statins prescribing: can the theory of planned behaviour explain physician behaviour in following guideline recommendations? J Eval Clin Pract. 2011; 17(4):749-57.
25. Chisholm MA, Williamson GM, Lance CE, Mulloy LL. Predicting adherence to immunosuppressant therapy: a prospective analysis of the theory of planned behaviour. Nephrol Dial Transplant. 2007;22(8):2339-48.
26. Patton MQ. Qualitative evaluation and research methods. 2nd ed. Newbury Park, CA: Sage; 1990.
27. Cohen D, Crabtree B. Qualitative research guidelines project. Available from: http://www.qualres.org/index.html. Cited 28 Dec 2011.
28. Bowen GA. Naturalistic inquiry and the saturation concept: a research note. Qual Res. 2008;8(1):137-52.
29. Whiteley AM, Whiteley J. The familiarization study in qualitative research: from theory to practice. Qual Res J. 2006;6(1): 69-85.
30. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277-88.
31. Commonwealth of Australia, The Pharmacy Guild of Australia. The fifth community pharmacy agreement between the Commonwealth of Australia and the Pharmacy Guild of Australia. 2010 [cited 7-Sep-2011]; Available from: http://www.health.gov. au/internet/main/publishing.nsf/Content/ C3DB799DB360AF0CCA25772000249FA8/$File/ 5CPA%20Agreement%2005%20August%202010.pdf.
32. Manley HJ, Garvin CG, Drayer DK, Reid GM, Bender WL, Neufeld TK, et al. Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not for-profit dialysis provider. Nephrol Dial Transplant. 2004;19(7): 1842-8.
33. Grabe DW, Low CL, Bailie GR, Eisele G. Evaluation of drugrelated problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol. 1997;47(2): 117-21.
34. Manley HJ, Drayer DK, McClaran M, Bender W, Muther RS. Drug record discrepancies in an outpatient electronic medical record: frequency, type, and potential impact on patient care at a hemodialysis center. Pharmacotherapy. 2003;23(2):231-9.
35. Mirkov S, Ball P. Design and pilot of a medication review clinic in a dialysis centre. J Pharm Pract. 2003;33(3):199-203.
36. Quercia RA, Abrahams R, White CM, D'Avella J, Campbell M. Cost avoidance and clinical benefits derived from a pharmacymanaged anemia program. Hosp Pharm. 2001;36(2):169-75.
37. Sulick JA, Pathak DS. The perceived influence of clinical pharmacy services on physician prescribing behavior: a matched-pair comparison of pharmacists and physicians. Pharmacotherapy. 1996;16(6):1133-41.
38. Hepler CD. A dream deferred. Am J Health Syst Pharm. 2010;67(16):1319-25.
39. Tahaineh LM, Wazaify M, Albsoul-Younes A, Khader Y, Zaidan M. Perceptions, experiences, and expectations of physicians in hospital settings in Jordan regarding the role of the pharmacist. Res Social Adm Pharm. 2009;5(1):63-70.
40. McGrath SH, Snyder ME, Duenas GG, Pringle JL, Smith RB, McGivney MS. Physician perceptions of pharmacist-provided medication therapy management: qualitative analysis. J Am Pharm Assoc (2003). 2010;50(1):67-71.
41. Brown CA, Bailey JH, Lee J, Garrett PK, Rudman WJ. The pharmacist-physician relationship in the detection of ambulatory medication errors. Am J Med Sci. 2006;331(1):22-4.
42. Makowsky MJ, Schindel TJ, Rosenthal M, Campbell K, Tsuyuki RT, Madill HM. Collaboration between pharmacists, physicians and nurse practitioners: a qualitative investigation of working relationships in the inpatient medical setting. J Interprof Care. 2009;23(2):169-84.